James A Rogers
Overview
Explore the profile of James A Rogers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tortorici M, Rogers J, Vit O, Bexon M, Sandhaus R, Burdon J, et al.
Br J Clin Pharmacol
. 2017 Jun;
83(11):2386-2397.
PMID: 28662542
Aims: Early-onset emphysema attributed to α-1 antitrypsin deficiency (AATD) is frequently overlooked and undertreated. RAPID-RCT/RAPID-OLE, the largest clinical trials of purified human α-1 proteinase inhibitor (A -PI; 60 mg kg ...
12.
Rogers J, Mishra M, Hahn J, Greene C, Yates R, Metz L, et al.
Proc Natl Acad Sci U S A
. 2017 Apr;
114(19):4999-5004.
PMID: 28439012
Environmental and hormonal factors are implicated in dysimmunity in multiple sclerosis. We investigated whether bisphenol-A, a prominent contaminant with endocrine-disrupting capabilities, altered susceptibility in an inflammatory model of multiple sclerosis....
13.
Johnson T, Wu Y, Nathoo N, Rogers J, Yong V, Dunn J
PLoS One
. 2016 Dec;
11(12):e0167196.
PMID: 27907119
Background: Multiple sclerosis (MS) has a significant inflammatory component and may have significant gray matter (GM) pathophysiology. Brain oxygenation is a sensitive measurement of the balance between metabolic need and...
14.
Keough M, Rogers J, Zhang P, Jensen S, Stephenson E, Chen T, et al.
Nat Commun
. 2016 Apr;
7:11312.
PMID: 27115988
Remyelination is the generation of new myelin sheaths after injury facilitated by processes of differentiating oligodendrocyte precursor cells (OPCs). Although this repair phenomenon occurs in lesions of multiple sclerosis patients,...
15.
Nathoo N, Rogers J, Yong V, Dunn J
PLoS One
. 2015 May;
10(5):e0127033.
PMID: 25992667
Susceptibility-weighted imaging (SWI) detects hypointensities due to iron deposition and deoxyhemoglobin. Previously it was shown that SWI detects hypointensities in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS),...
16.
Rogers J, Metz L, Yong V
Mol Immunol
. 2012 Nov;
53(4):421-30.
PMID: 23123408
Endocrine disrupting chemicals (EDCs) have become of concern for a variety f health issues. Due to their effects on the endocrine system they have been thoroughly examined with regards to...
17.
Rogers J, Polhamus D, Gillespie W, Ito K, Romero K, Qiu R, et al.
J Pharmacokinet Pharmacodyn
. 2012 Jul;
39(5):479-98.
PMID: 22821139
Our objective was to develop a beta regression (BR) model to describe the longitudinal progression of the 11 item Alzheimer's disease (AD) assessment scale cognitive subscale (ADAS-cog) in AD patients...
18.
Riggs M, Bergsma T, Rogers J, Gastonguay M, Subramanian G, Chen C, et al.
J Clin Pharmacol
. 2011 May;
52(4):475-86.
PMID: 21551316
Albinterferon alfa-2b (albIFN) has been studied for treatment of chronic hepatitis C virus (HCV). A population pharmacokinetics model was developed using nonlinear mixed-effects modeling. Efficacy/safety exposure-response relationships were assessed for...
19.
Gastonguay M, French J, Heitjan D, Rogers J, Ahn J, Ravva P
J Clin Pharmacol
. 2010 Oct;
50(9 Suppl):63S-74S.
PMID: 20881220
No abstract available.
20.
Han M, Rogers J, Lavingia B, Stastny P
Hum Immunol
. 2008 Nov;
70(1):29-34.
PMID: 19026703
Donor-specific HLA antibodies have been associated with acute and chronic rejection. Such antibodies may sometimes not be detected in recipient serum. In an attempt to learn about possible mechanisms, we...